Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Krishna Institute of Medical Sciences Limited ( (IN:KIMS) ) just unveiled an update.
Krishna Institute of Medical Sciences Limited has announced that its top management, including Founder and Managing Director Dr. Bhaskara Rao Bollineni, Executive Director and CEO Dr. Abhinay Bollineni, and Chief Financial Officer Mr. Sachin Salvi, will participate in an earnings conference call hosted by IIFL Capital on 7 February 2026. The call, which follows the release of the company’s third-quarter FY26 financial results, is intended for analysts and investors and will focus on discussing KIMS’s business strategy and outlook, underscoring the company’s efforts to maintain transparent communication with the market and provide stakeholders with deeper insight into its operational and strategic priorities.
More about Krishna Institute of Medical Sciences Limited
Krishna Institute of Medical Sciences Limited (KIMS Hospitals) operates in the healthcare services industry, running a network of multi-specialty hospitals that provide a wide range of medical and surgical services. The company focuses on delivering tertiary and quaternary care, positioning itself as a key regional healthcare provider in India and attracting both domestic and international patients seeking advanced clinical treatments.
Average Trading Volume: 45,668
Technical Sentiment Signal: Sell
Current Market Cap: 241.5B INR
For detailed information about KIMS stock, go to TipRanks’ Stock Analysis page.